// PERSON
Jennifer Doudna
ROLE CO-FOUNDERAT SPR THERAPEUTICSMENTIONS 1LAST SEEN JULY 27, 2026
// RECENT MENTIONS
// SIGNALS
1 SIGNAL
01
funding·Axios Pro Rata·JULY 27, 2026
“Scribe Therapeutics, Molecular engineering / CRISPR startup, Successful IPO, priced at high end, closed 44% above IPO price. 'raised $129m in its IPO... closed Friday trading at $21.65'”
AI-extracted from podcast / newsletter / paper summaries. May contain errors.